Publications 2013 [References 614–670]

614. Guo B, Page A, Wang H, Taylor R, McIntyre P. Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China. Vaccine 2013;31:603-17. [Abstract]

615. Trauer JM, Bandaranayake D, Booy R, Chen MI, Cretikos M, Dowse GK, Dwyer DE, Greenberg ME, Huang QS, Khandaker G, Kok J, Laurie KL, Lee VJ, McVernon J, Walter S, Markey PG. Seroepidemiologic effects of influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore. Emerging Infectious Diseases 2013;19:92-101. [Full text]

616. Gao Z, Wood JG, Burgess MA, Menzies RI, McIntyre PB, Macintyre CR. Models of strategies for control of rubella and congenital rubella syndrome–a 40 year experience from Australia. Vaccine 2013;31:691-7. [Abstract]

617. Jayasinghe S, Macartney K. Estimating rotavirus gastroenteritis hospitalisations by using hospital episode statistics before and after the introduction of rotavirus vaccine in Australia. Vaccine 2013;31:967-72. [Abstract]

618. Wiley KE, Zuo Y, Macartney KK, McIntyre PB. Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy. Vaccine 2013;31:618-25. [Abstract]

619. Crosbie C, Richters J, Hooker C and Leask J. Filthy fingernails and friendly germs: Lay concepts of contagious disease transmission in developed countries. In: Banwell C, Ulijaszek S, Dixon J. When culture impacts health. 1st ed. London: Elsevier; 2013.

620. McIntyre PB, Sintchenko V. The "how" of polymerase chain reaction testing for Bordetella pertussis depends on the "why". Clinical Infectious Diseases 2013;56:332-4. [Abstract]

621. Booy R, Richmond P, Nolan T, McVernon J, Marshall H, Nissen M, Reynolds G, 2nd, Ziegler JB, Stoney T, Heron L, Lambert S, Mesaros N, Peddiraju K, Miller JM. Three-year antibody persistence and safety following a single dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in Hib-primed toddlers. Pediatric Infectious Disease Journal 2013;32:169-74. [Abstract]

622. Sweeney F, Viner RM, Booy R, Christie D. Parents' experiences of support during and after their child's diagnosis of meningococcal disease. Acta Paediatrica 2013;102:e126-30. [Abstract]

623. Hull BP, Menzies R, Macartney K, McIntyre PB. Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: the Australian experience. Vaccine 2013;31:1964-9. [Abstract]

624. Cashmore AW, Muscatello DJ, Merrifield A, Spokes P, Macartney K, Jalaludin BB. Relationship between the population incidence of pertussis in children in New South Wales, Australia and emergency department visits with cough: a time series analysis. BMC Medical Informatics and Decision Making 2013;13:40. [Full text]

625. Wiley K, Leask J. Respiratory vaccine uptake during pregnancy [comment]. Lancet Respiratory Medicine 2013;1:9-11. [No abstract available]

626. Marshall HS, McIntyre P, Richmond P, Buttery JP, Royle JA, Gold MS, Wood N, Elliott EJ, Zurynski Y, Toi CS, Dwyer DE, Booy R. Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in Australia. Pediatric Infectious Disease Journal 2013;32:530-7. [Abstract]

627. Hull B, Dey A, Menzies R, McIntyre P. Annual Immunisation Coverage Report, 2010. Communicable Diseases Intelligence 2013;37:E21-39. [Full text]

628. Kilham HA, Leask J. The Royal Australasian College of Physicians immunisation position statement. Journal of Paediatrics and Child Health 2013;49:427-31. [No abstract available]

629. Chiu C, McIntyre P. Pneumococcal vaccines: past, present and future. Australian Prescriber 2013;36:88-93. [Full text]

630. Ward K, Hull BP, Leask J. Financial incentives for childhood immunisation - a unique but changing Australian initiative [erratum appears in Med J Aust 2013 Jul 8;199(1):29]. Medical Journal of Australia 2013;198:590-2. [Full text]

631. Haworth E, Barasheed O, Memish ZA, Rashid H, Booy R. Prevention of influenza at Hajj: applications for mass gatherings. Journal of the Royal Society of Medicine 2013;106:215-23. [Abstract]

632. Abbott P, Menzies R, Davison J, Moore L, Wang H. Improving immunisation timeliness in Aboriginal children through personalised calendars. BMC Public Health 2013;13:598. [Full text]

633. Zurynski Y, McIntyre P, Booy R, Elliott EJ, on behalf of the PAEDS Investigators Group. Paediatric Active Enhanced Disease Surveillance: a new surveillance system for Australia. Journal of Paediatrics and Child Health 2013;49:588-94. [Abstract]

634. Larson H, Leask J, Aggett S, Sevdalis N, Thomson A. A multidisciplinary research agenda for understanding vaccine-related decisions. Vaccines 2013;1:293-304. [Full text]

635. Esterman EE, Lahra MM, Zurynski YA, Booy R, Elliott EJ. Influenza infection in infants aged <6 months during the H1N1-09 pandemic: a hospital-based case series. Journal of Paediatrics and Child Health 2013;49:635-40. [Abstract]

636. Smith BB, Hazelton BJ, Heywood AE, Snelling TL, Peacock KM, Macartney KK. Disseminated tuberculosis and tuberculous meningitis in Australian-born children; case reports and review of current epidemiology and management. Journal of Paediatrics and Child Health 2012;49:E246-50. [Abstract]

637. Wiley KE, Massey PD, Cooper Robbins SC, Wood NJ, Ho J, Quinn HE, Leask J. Uptake of influenza vaccine by pregnant women: a cross-sectional survey. Medical Journal of Australia 2013;198:373-5. [Full text]

638. Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews 2013;(6):CD004405. doi:10.1002/14651858.CD004405.pub4. [Abstract]

639. Ward K, Dey A, Hull B, Quinn HE, Macartney K, Menzies R. Evaluation of Australia's varicella vaccination program for children and adolescents. Vaccine 2013;31:1413-9. [Abstract]

640. Macartney KK, Chiu C, Georgousakis M, Brotherton JM. Safety of human papillomavirus vaccines: a review. Drug Safety 2013;36:393-412. [Abstract]

641. Chow MY, Morrow AM, Booy R, Leask J. Impact of children's influenza-like illnesses on parental quality of life: a qualitative study. Journal of Paediatrics and Child Health 2013;49:664-70. [Abstract]

642. Wiley KE, Massey PD, Cooper SC, Wood N, Quinn HE, Leask J. Pregnant women's intention to take up a post-partum pertussis vaccine, and their willingness to take up the vaccine while pregnant: a cross sectional survey. Vaccine 2013;31:3972-8. [Abstract]

643. Menzies RI, Markey P, Boyd R, Koehler AP, McIntyre PB. No evidence of increasing Haemophilus influenzae non-b infection in Australian Aboriginal children. International Journal of Circumpolar Health 2013;72:20992. [Full text]

644. Dodd CN, Romio SA, Black S, et al (including Macartney K). International collaboration to assess the risk of Guillain Barré syndrome following influenza A (H1N1) 2009 monovalent vaccines. Vaccine 2013;31:4448-58. [Abstract]

645. O'Grady KA, Grimwood K, Cripps A, Mulholland EK, Morris P, Torzillo PJ, Wood N, Smith-Vaughan H, Revell A, Wilson A, Van Asperen P, Richmond P, Thornton R, Rablin S, Chang AB. Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial. Trials 2013;14:282. [Full text]

646. Ward K, Quinn H, Menzies R, McIntyre P. A history of adolescent school-based vaccination in Australia. Communicable Diseases Intelligence 2013;37:E168-74. [Full text]

647. Ward K, Quinn H, Bachelor M, Bryant V, Campbell-Lloyd S, Newbound A, Skully M, Webby R, McIntyre PB. Adolescent school-based vaccination in Australia. Communicable Diseases Intelligence 2013;37:E156-67. [Full text]

648. Mahajan D, Cook J, Dey A, Macartney K, Menzies R. Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2012. Communicable Diseases Intelligence 2013;37:E130-4. [Full text]

649. Rashid H, Barasheed O, Booy R. Acute febrile respiratory infection symptoms in Australian Hajjis at risk of exposure to Middle East respiratory syndrome coronavirus [letter]. Medical Journal of Australia 2013;199:453. [Full text]

650. Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O'Brien KL, Moore MR, the Serotype Replacement Study Group (including McIntyre P, Menzies R, Jayasinghe S). Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Medicine 2013;10:e1001517. [Full text]

651. Georgousakis M, Dierig A, Booy R. Immunisation and infectious diseases. In: Steinbeck K, Kohn M (editors). A clinical handbook in adolescent medicine: A guide for health professionals who work with adolescents and young adults. Singapore: World Scientific Publishing Co; 2013. p. 421-38. [No abstract available]

652. Edwards KM, Booy R. Effects of exercise on vaccine-induced immune responses. Human Vaccines and Immunotherapeutics 2013;9:907-10. [Abstract]

653. Rashid H, Heron L. 'Oseltamivir hot topic issue': a one-stop shop for oseltamivir [editorial]. Infectious Disorders – Drug Targets 2013;13:1. [Full text]

654. Dixit R, Khandaker G, Ilgoutz S, Rashid H, Booy R. Emergence of oseltamivir resistance: control and management of influenza before, during and after the pandemic. Infectious Disorders – Drug Targets 2013;13:34-45. [Full text]

655. Tashani M, Rashid H, Ridda I, Heron L, Memish ZA, Haworth E, Booy R. Oseltamivir for control of influenza at mass gatherings. Infectious Disorders – Drug Targets 2013;13:46-52. [Full text]

656. Yin JK, Heron L, Salkeld G, Rashid H, Booy R. Oseltamivir use in adolescents and adults: clinical and economic considerations. Infectious Disorders – Drug Targets 2013;13:53-8. [Full text]

657. Carlin JB, Macartney K, Lee KJ, Quinn HE, Buttery J, Lopert R, Bines J, McIntyre P. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's national immunisation program. Clinical Infectious Diseases 2013;57:1427-34. [Abstract]

658. Maher L, Hope K, Torvaldsen S, Lawrence G, Dawson A, Wiley K, Thomson D, Hayen A, Conaty S. Influenza vaccination during pregnancy: coverage rates and influencing factors in two urban districts in Sydney. Vaccine 2013;31:5557-64. [Abstract]

659. Yin JK, Salkeld G, Lambert SB, Dierig A, Heron L, Leask J, Chow MY, Booy R. Estimates and determinants of economic impacts from influenza-like illnesses caused by respiratory viruses in Australian children attending childcare: a cohort study. Influenza and Other Respiratory Viruses 2013;7:1103-12. [Full text]

660. Naidu L, Chiu C, Habig A, Lowbridge C, Jayasinghe S, Wang H, McIntyre P, Menzies R. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006–2010. Communicable Diseases Intelligence 2013;37 Suppl:S1-95. [Full text]

661. Chow MY, Morrow AM, Cooper Robbins SC, Leask J. Condition-specific quality of life questionnaires for caregivers of children with pediatric conditions: a systematic review. Quality of Life Research 2013;22:2183-200. [Abstract]

662. Khandaker G, Heron L, Rashid H, Li-Kim-Moy J, Lester-Smith D, Kesson A, McCaskill M, Jones C, Zurynski Y, Elliott EJ, Dwyer DE, Booy R. Comparing the use of, and considering the need for, lumbar puncture in children with influenza or other respiratory virus infections. Influenza and Other Respiratory Viruses 2013;7:932-7. [Full text]

663. Rashid H, Abdul Muttalif AR, Mohamed Dahlan ZB, Djauzi S, Iqbal Z, Karim HM, Naeem SM, Tantawichien T, Zotomayor R, Patil S, Schmitt HJ. The potential for pneumococcal vaccination in Hajj pilgrims: expert opinion. Travel Medicine and Infectious Disease 2013;11:288-94. [Abstract]

664. Leask J, Cheater F, Kinnersley P, Willaby H, Danchin M. Presumptive initiations in vaccine discussions with parents: acquiescence but at what cost? Pediatrics 2013; December 13: [e-letter]. [Full text]

665. Gunaratnam PJ, Gilmour RE, Lowbridge C, McIntyre PB. Bug Breakfast in the Bulletin: Invasive pneumococcal disease. New South Wales Public Health Bulletin 2013;24:142. [Full text]

666. Hull B. Australian childhood immunisation coverage, 1 April to 30 June cohort, assessed as at 30 September 2012 [quarterly report]. Communicable Diseases Intelligence 2013;37:E274-5. [Full text]

667. Hull B. Australian childhood immunisation coverage, 1 October to 31 December cohort, assessed as at 31 March 2013 [quarterly report]. Communicable Diseases Intelligence 2013;37:E276-7. [Full text]

668. Hull BP, Dey A, Menzies RI, Brotherton JM, McIntyre PB. Immunisation coverage annual report, 2011. Communicable Diseases Intelligence 2013;37:E291-312. [Full text]

669. Hull BP. Australian childhood immunisation coverage, 1 January to 31 March cohort, assessed as at 30 June 2013 [quarterly report]. Communicable Diseases Intelligence 2013;37:E434-5. [Full text]

670. Lambert SB, Chuk LM, Nissen MD, Nolan TM, McVernon J, Booy R, Heron L, Richmond PC, Walls T, Marshall HS, Reynolds GJ, Hartel GF, Hu W, Lai MH. Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents. Influenza and Other Respiratory Viruses 2013;7:676-85. [Full text]